| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 31 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 31 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 31 |
| 3 | METHYLPREDNISOLONE | 22 |
| 4 | RITUXIMAB | 19 |
| 5 | ANTI ITCH | 17 |
| 6 | ANTI-ITCH | 17 |
| 7 | ANTI-ITCH CREAM | 17 |
| 8 | ANTI-PRURITIC | 17 |
| 9 | ANTIPRURITIC (ANTI-ITCH) | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERAVACYCLINE | 1 | 0.0034 |
| 1 | DALBAVANCIN HYDROCHLORIDE | 1 | 0.0021 |
| 2 | IPTACOPAN | 1 | 0.0013 |
| 3 | LISOCABTAGENE MARALEUCEL | 1 | 0.0011 |
| 4 | METHIMAZOLE | 8 | 0.0010 |
| 5 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 2 | 0.0008 |
| 6 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 7 | EPOPROSTENOL | 7 | 0.0005 |
| 8 | MINOCYCLINE | 6 | 0.0005 |
| 9 | AMPHOTERICIN B | 6 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0008 |
| 1 | Thyroid Hormone Synthesis Inhibitor [EPC] | 8 | 0.0008 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 6 | 0.0005 |
| 3 | Penem Antibacterial [EPC] | 14 | 0.0004 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 5 | Oxazolidinone Antibacterial [EPC] | 7 | 0.0002 |
| 6 | Antiparasitic [EPC] | 1 | 0.0002 |
| 7 | Pediculicide [EPC] | 1 | 0.0002 |
| 8 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 4 | 0.0002 |